Organization profile

Organization profile

The mission of the Center for Translational Medicine is to support the development of novel, investigator-initiated treatment strategies in order to facilitate the implementation of new therapies for patients and achieve new breakthroughs in medicine at the University. The Center has a well-equipped lab and a full-time staff and provides the infrastructure, expertise and resources necessary to translate innovative drugs, biological reagents and devices into Phase 1 clinical trials.  Working with innovators from across the University, the Center designs and conducts the preclinical studies necessary for IND/IDE development and supports Phase I clinical trial design and implementation, including manufacture of clinical product.

 

Fingerprint Dive into the research topics where Center for Translational Medicine is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Lia G Coicou

    Lia G Coicou

    Person: Researcher

    No photo of Craig M Flory

    Craig M Flory

    Person: Researcher

    19892019
    No photo of Brenda Koniar

    Brenda Koniar

    Person: Research Support

    Projects

    Research Output

    Clinical and microbiologic investigation of an expedited peri-implantitis dog model: An animal study

    Seong, W. J., Kotsakis, G., Huh, J. K., Jeong, S. C., Nam, K. Y., Kim, J. R., Heo, Y. C., Kim, H. C., Zhang, L., Evans, M. D., Conrad, H. & Schumacher, R. J., Jul 15 2019, In : BMC Oral Health. 19, 1, 150.

    Research output: Contribution to journalArticle

    Open Access
  • In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K

    Gorr, S. U., Flory, C. M. & Schumacher, R. J., May 2019, In : PloS one. 14, 5, e0216669.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity

    Oppegard, L. M., Delgado, J. L., Kulkarni, C. A., Towle, T. R., Hart, D. E., Williams, B. P., Lentz, S. R. C., Norris, B., Flory, C. M., Schumacher, R. J., Murry, D. J., Kerns, R. J. & Hiasa, H., Apr 15 2019, In : Investigational New Drugs. 37, 2, p. 378-383 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations